相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cellular retinoic acid binding protein I mediates rapid non-canonical activation of ERK1/2 by all-trans retinoic acid
Shawna D. Persaud et al.
CELLULAR SIGNALLING (2013)
Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma
Yangyang Hu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Protective effect of celastrol in rat cerebral ischemia model: Down-regulating p-JNK, p-c-Jun and NF-κB
Yanhua Li et al.
BRAIN RESEARCH (2012)
TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans- retinoic acid
Muhammad Imran et al.
EUROPEAN JOURNAL OF CANCER (2012)
Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90
Wen-Bo Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Ursolic acid induces HL60 monocytic differentiation and upregulates C/EBPβ expression by ERK pathway activation
Ting Zhang et al.
ANTI-CANCER DRUGS (2011)
Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
Radhamani Kannaiyan et al.
CANCER LETTERS (2011)
Advances in therapies for acute promyelocytic leukemia
Tomohiko Kamimura et al.
CANCER SCIENCE (2011)
Differentiation syndrome in patients with acute promyelocytic leukemia
Jane E Rogers et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2011)
The Differentiation Syndrome in Patients with Acute Promyelocytic Leukemia: Experience of the Pethema Group and Review of the Literature
Pau Montesinos et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2011)
Celastrol Attenuates Hypertension-Induced Inflammation and Oxidative Stress in Vascular Smooth Muscle Cells via Induction of Heme Oxygenase-1
Xiao Yu et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Celastrol: Molecular targets of Thunder God Vine
Antero Salminen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Celastrol Acts as a Potent Antimetastatic Agent Targeting β1 Integrin and Inhibiting Cell-Extracellular Matrix Adhesion, in Part via the p38 Mitogen-Activated Protein Kinase Pathway
Hong Zhu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way
Bin Peng et al.
MOLECULAR CANCER (2010)
Celastrol binds to ERK and inhibits FcεRI signaling to exert an anti-allergic effect
Youngmi Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Acute promyelocytic leukemia: Recent advances in diagnosis and management
Francesco Lo-Coco et al.
SEMINARS IN ONCOLOGY (2008)
Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-κB in LPS-stimulated BV-2 microglial cells
Hyo Won Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
Adhesion molecules and differentiation syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia
Gil Cunha De Santis et al.
HAEMATOLOGICA (2007)
The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia
Adriana I. Dore et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Tripterine inhibits the expression of adhesion molecules in activated endothelial cells
Deng-Hai Zhang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Naturally occurring NF-κB inhibitors
Nguyen-Hai Nam
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Retinoic acid syndrome in NOD/scid mice induced by injecting an acute promyelocytic leukemia cell line
M Ninomiya et al.
LEUKEMIA (2004)
Retinoic acid syndrome: manifestations, pathogenesis, and treatment
RS Larson et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2003)
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia
M Konopleva et al.
BLOOD (2002)
Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease
AC Allison et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2001)